MASP1 and infection: In conclusion, the characteristic “double-edge” association of MASP-2 (and probably also of MASP-1 and other LP components) with immunosuppression, infection and inflammation poises a difficult question regarding therapies directed to its inhibition, motivating further investigations in this field (Figure 5).